Trial Outcomes & Findings for Mindfulness-Based Stress Reduction for Adults With Low-Risk Chest Pain Associated With Anxiety (NCT NCT03365375)
NCT ID: NCT03365375
Last Updated: 2024-01-24
Results Overview
Difference in GAD-7 score at enrollment compared to assessment at 3 months. Anxiety Severity by total score. Range 0-21. Mild 5-9; Moderate (10-14); Severe \> 15
COMPLETED
NA
28 participants
Measured at 3 months
2024-01-24
Participant Flow
We screened patients who presented to the Emergency Department (ED) with chest pain. We assessed their risk for major adverse cardiac events (MACE) using the HEART score and for anxiety with the GAD-7. Enrolled subjects were assigned to either arm depending upon enrollment period. In the 8 weeks prior to the MBSR course commencement all subjects enrolled were assigned to Arm 2: MBSR. This period was immediately followed by 8 weeks of enrollment in Arm 1: Standard Referral.
Participant milestones
| Measure |
Usual Care Referral
Subjects will be referred for primary care provider (PCP) follow up and/or to psychiatry for further management and treatment of elevated anxiety levels according to standard of care.
|
MBSR Referral
MBSR Referral: Referral for mindfulness-based stress reduction (MBSR), a structured meditation training program consisting of 8 weekly group sessions.
|
|---|---|---|
|
Overall Study
STARTED
|
14
|
14
|
|
Overall Study
COMPLETED
|
14
|
9
|
|
Overall Study
NOT COMPLETED
|
0
|
5
|
Reasons for withdrawal
| Measure |
Usual Care Referral
Subjects will be referred for primary care provider (PCP) follow up and/or to psychiatry for further management and treatment of elevated anxiety levels according to standard of care.
|
MBSR Referral
MBSR Referral: Referral for mindfulness-based stress reduction (MBSR), a structured meditation training program consisting of 8 weekly group sessions.
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
0
|
1
|
|
Overall Study
Lost to Follow-up
|
0
|
4
|
Baseline Characteristics
Mindfulness-Based Stress Reduction for Adults With Low-Risk Chest Pain Associated With Anxiety
Baseline characteristics by cohort
| Measure |
Usual Care Referral
n=14 Participants
Subjects will be referred for primary care provider (PCP) follow up and/or to psychiatry for further management and treatment of elevated anxiety levels according to standard of care.
|
MBSR Referral
n=14 Participants
MBSR Referral: Referral for mindfulness-based stress reduction (MBSR), a structured meditation training program consisting of 8 weekly group sessions.
|
Total
n=28 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
43.3 years
STANDARD_DEVIATION 9.3 • n=5 Participants
|
38.9 years
STANDARD_DEVIATION 11.9 • n=7 Participants
|
41.2 years
STANDARD_DEVIATION 11.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
11 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
13 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
6 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
GAD-7 at enrollment
|
15.9 units on a scale
STANDARD_DEVIATION 4.4 • n=5 Participants
|
14.9 units on a scale
STANDARD_DEVIATION 3.1 • n=7 Participants
|
15.3 units on a scale
STANDARD_DEVIATION 3.6 • n=5 Participants
|
PRIMARY outcome
Timeframe: Measured at 3 monthsDifference in GAD-7 score at enrollment compared to assessment at 3 months. Anxiety Severity by total score. Range 0-21. Mild 5-9; Moderate (10-14); Severe \> 15
Outcome measures
| Measure |
Usual Care Referral
n=12 Participants
Subjects will be referred for primary care provider (PCP) follow up and/or to psychiatry for further management and treatment of elevated anxiety levels according to standard of care.
|
MBSR Referral
n=6 Participants
MBSR Referral: Referral for mindfulness-based stress reduction (MBSR), a structured meditation training program consisting of 8 weekly group sessions.
|
|---|---|---|
|
Mean Difference in Generalized Anxiety Disorder -7 (GAD-7)
|
5.3 score on a scale
Standard Deviation 5.4
|
3.2 score on a scale
Standard Deviation 8.1
|
SECONDARY outcome
Timeframe: Measured at 45 days, 6 months, and 12 monthsAnxiety Severity by total score. Range 0-21. Mild 5-9; Moderate (10-14); Severe \> 15
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 monthsReturn visits to the Emergency Department
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 monthsquality of life
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 months12-item measure (each scored 1-4) with total of 48. A higher score is consistent with greater mindfulness qualities.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 months13-item state-mindfulness measure that has two sub-scales: Curiosity, 6 items, subscale score ranging from 0-24, and Decentering, 7 items, with a subscale score ranging from 0-28.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 monthsMeasure of current depression: None - Minimal depression (0 to 4), Mild depression (5 to 9), Moderate depression (10 to 14), Moderately severe depression (15 to 19), Severe depression (20 to 24)
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 monthsSomatic symptom severity: Minimal 0-4, Low 5-9, Medium 10-14, High 15-30
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 monthsVisits to care professionals other then the ED
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 months4 item measure (each scored 0 or 1). Higher score associated with higher likelihood of a PTSD.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 months5 item measure (each scored 0 or 1). Higher score associated with higher likelihood of a panic disorder.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at 45 days, 3 months, 6 months, and 12 months3 item measure (each scored 1-4) with total possible score of 12. Higher score associated with higher social anxiety
Outcome measures
Outcome data not reported
Adverse Events
Usual Care Referral
MBSR Referral
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place